Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology
- PMID: 32911102
- DOI: 10.1016/j.actbio.2020.09.009
Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology
Abstract
Mesoporous silica nanoparticles (MSNs) have received increasing interest due to their tunable particle size, large surface area, stable framework, and easy surface modification. They are increasingly being used in varying applications as delivery vehicles including bio-imaging, drug delivery, biosensors and tissue engineering etc. Precise structure control and the ability to modify surface properties of MSNs are important for their applications. This review summarises the different synthetic methods for the preparation of well-ordered MSNs with tunable pore volume as well as the approaches of drugs loading, especially highlighting the facile surface functionalization for various purposes and versatile biomedical applications in oncology. Finally, the challenges of clinical transformation of MSNs-based nanomedicines are further discussed.
Keywords: Biomedical application; Drug delivery; Mesoporous silica nanoparticles; Surface functionalization; Synthesis method.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of Competing Interest There are no conflicts to declare.
Similar articles
-
Multifunctional mesoporous silica nanoparticles for biomedical applications.Signal Transduct Target Ther. 2023 Nov 24;8(1):435. doi: 10.1038/s41392-023-01654-7. Signal Transduct Target Ther. 2023. PMID: 37996406 Free PMC article. Review.
-
Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery.Expert Opin Drug Deliv. 2019 Mar;16(3):219-237. doi: 10.1080/17425247.2019.1575806. Epub 2019 Feb 7. Expert Opin Drug Deliv. 2019. PMID: 30686075 Review.
-
Mesoporous silica nanoparticles for therapeutic/diagnostic applications.Biomed Pharmacother. 2019 Jan;109:1100-1111. doi: 10.1016/j.biopha.2018.10.167. Epub 2018 Nov 6. Biomed Pharmacother. 2019. PMID: 30551360 Review.
-
In vivo bio-safety evaluations and diagnostic/therapeutic applications of chemically designed mesoporous silica nanoparticles.Adv Mater. 2013 Jun 18;25(23):3144-76. doi: 10.1002/adma.201205292. Epub 2013 May 17. Adv Mater. 2013. PMID: 23681931 Review.
-
Chemical Synthesis and Multihybridization of Small-Sized Hollow Mesoporous Organosilica Nanoparticles Toward Advanced Theranostics.Acc Chem Res. 2024 Dec 17;57(24):3465-3477. doi: 10.1021/acs.accounts.4c00502. Epub 2024 Nov 22. Acc Chem Res. 2024. PMID: 39576957 Review.
Cited by
-
Advances in smart nanotechnology-supported photodynamic therapy for cancer.Cell Death Discov. 2024 Nov 11;10(1):466. doi: 10.1038/s41420-024-02236-4. Cell Death Discov. 2024. PMID: 39528439 Free PMC article. Review.
-
Multifunctional mesoporous silica nanoparticles for biomedical applications.Signal Transduct Target Ther. 2023 Nov 24;8(1):435. doi: 10.1038/s41392-023-01654-7. Signal Transduct Target Ther. 2023. PMID: 37996406 Free PMC article. Review.
-
Thin-Film Composite Membrane with Porous Interlayer Composed of Dendritic Mesoporous Silica Nanoparticles for Enhanced Nanofiltration.Polymers (Basel). 2023 Sep 28;15(19):3912. doi: 10.3390/polym15193912. Polymers (Basel). 2023. PMID: 37835961 Free PMC article.
-
Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges.J Nanobiotechnology. 2023 Sep 8;21(1):325. doi: 10.1186/s12951-023-02093-w. J Nanobiotechnology. 2023. PMID: 37684605 Free PMC article. Review.
-
Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.Pharmaceutics. 2021 Jan 24;13(2):152. doi: 10.3390/pharmaceutics13020152. Pharmaceutics. 2021. PMID: 33498885 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources